The ABTA relies on leaders in the brain tumor community to make sure the work we do is meaningful and accurate. Our Scientific Advisory Council makes research funding recommendations to the ABTA board of directors, and also advises the ABTA about scientific trends and new areas of research. Our Clinical Advisory Council reviews our publications and other content we put out to make sure everything is clinically up to date.

Scientific Advisory Council

Peter C. Burger, MD
Professor of Pathology, Neurosurgery, Oncology

Johns Hopkins University Hospital

Baltimore, Maryland

Webster K. Cavenee, PhD
Director of Strategic Alliances in Central Nervous System Cancers, Ludwig Institute for Cancer Research

University of California, San Diego

San Diego, California

E. Antonio Chiocca, MD, PhD
Harvey W. Cushing Professor of Neurosurgery, Harvard Medical School; Neurosurgeon-in-Chief and Chairman, Department of Neurosurgery; Co-Director, Institute for the Neurosciences at the Brigham Brigham and WomenÕs/Faulkner Hospital Surgical Director, Center for Neuro-Oncology

Brigham and WomenÕs and Dana-Farber Cancer Institute

Boston, Massachusetts

Henry S. Friedman, MD
Professor of Neurosurgery, James B. Powell, Jr. Professor of Pediatric Oncology, Assistant Professor of Pathology, Associate Professor of Medicine, Professor of Pediatrics, The Preston Robert Tisch Brain Tumor Center

Duke University Medical Center

Durham, North Carolina

G. Yancey Gillespie, PhD
Professor of Surgery, Microbiology, Cell Biology; Co-Director of the UAB Brain Tumor SPORE

University of Alabama at Birmingham

Birmingham, Alabama

William Hahn, MD, PhD
Professor of Medicine, Harvard Medical School; Director, Center for Cancer Genome Discovery, Dana-Farber Cancer Institute; Chief, Division of Molecular and Cellular Oncology, Medical Oncology; Professor of Medicine, Medical Oncology, Dana-Farber Cancer Institute

Harvard Medical School and Dana-Farber Cancer Institute

Boston, Massachusetts

en English
2019 National Conference Register Here